Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor?
Marta Zagrebelsky
Martin Korte
Keywords：Alzheimer's diseasebrain-derived neurotrophic factordepressionParkinson's diseasetropomyosin receptor kinase B receptor
Publication Date：2024-01-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 29-34 )